289 related articles for article (PubMed ID: 33174028)
41. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
[TBL] [Abstract][Full Text] [Related]
42. S100A8/A9: From basic science to clinical application.
Pruenster M; Vogl T; Roth J; Sperandio M
Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
[TBL] [Abstract][Full Text] [Related]
43. Advanced glycation end-products and Porphyromonas gingivalis lipopolysaccharide increase calprotectin expression in human gingival epithelial cells.
Hiroshima Y; Sakamoto E; Yoshida K; Abe K; Naruishi K; Yamamoto T; Shinohara Y; Kido JI; Geczy CL
J Cell Biochem; 2018 Feb; 119(2):1591-1603. PubMed ID: 28771806
[TBL] [Abstract][Full Text] [Related]
44. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.
Duan L; Wu R; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zuo G; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
PLoS One; 2013; 8(4):e62092. PubMed ID: 23637971
[TBL] [Abstract][Full Text] [Related]
45. Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue.
Van Crombruggen K; Vogl T; Pérez-Novo C; Holtappels G; Bachert C
Eur Respir J; 2016 Jan; 47(1):264-74. PubMed ID: 26493794
[TBL] [Abstract][Full Text] [Related]
46. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway.
Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z
Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437
[TBL] [Abstract][Full Text] [Related]
47. Effect of advanced glycation end products on lectin-like oxidized low density lipoprotein receptor-1 expression in endothelial cells.
Shiu SW; Wong Y; Tan KC
J Atheroscler Thromb; 2012; 19(12):1083-92. PubMed ID: 22863784
[TBL] [Abstract][Full Text] [Related]
48. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
49. S100A8/A9 in Myocardial Infarction.
Sreejit G; Nooti SK; Athmanathan B; Nagareddy PR
Methods Mol Biol; 2019; 1929():739-754. PubMed ID: 30710308
[TBL] [Abstract][Full Text] [Related]
50. S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells.
Qin F; Song Y; Li Z; Zhao L; Zhang Y; Geng L
Pathol Oncol Res; 2010 Sep; 16(3):353-60. PubMed ID: 19957061
[TBL] [Abstract][Full Text] [Related]
51. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2.
Ghavami S; Kerkhoff C; Chazin WJ; Kadkhoda K; Xiao W; Zuse A; Hashemi M; Eshraghi M; Schulze-Osthoff K; Klonisch T; Los M
Biochim Biophys Acta; 2008 Feb; 1783(2):297-311. PubMed ID: 18060880
[TBL] [Abstract][Full Text] [Related]
52. Association Between Clinicopathological Parameters and S100A8/A9 Expression According to Smoking History in Patients With Non-small Cell Lung Cancer.
Cho SB; Kim IK; Yeo CD; Lee SH
In Vivo; 2024; 38(1):474-481. PubMed ID: 38148054
[TBL] [Abstract][Full Text] [Related]
53. Hydroxytyrosol contributes to cell proliferation and inhibits apoptosis in pulsed electromagnetic fields treated human umbilical vein endothelial cells in vitro.
Cheng Y; Qu Z; Fu X; Jiang Q; Fei J
Mol Med Rep; 2017 Dec; 16(6):8826-8832. PubMed ID: 28990042
[TBL] [Abstract][Full Text] [Related]
54. Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling.
Nakao T; Shiota M; Tatemoto Y; Izumi Y; Iwao H
J Pharmacol Sci; 2007 Dec; 105(4):334-41. PubMed ID: 18057776
[TBL] [Abstract][Full Text] [Related]
55. Regulation of S100As Expression by Inflammatory Cytokines in Chronic Lymphocytic Leukemia.
Mitrović Ajtić O; Subotički T; Diklić M; Đikić D; Vukotić M; Dragojević T; Živković E; Antić D; Čokić V
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805957
[TBL] [Abstract][Full Text] [Related]
56. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.
Boyd JH; Kan B; Roberts H; Wang Y; Walley KR
Circ Res; 2008 May; 102(10):1239-46. PubMed ID: 18403730
[TBL] [Abstract][Full Text] [Related]
57. S100A8 and S100A9 in Cancer.
Chen Y; Ouyang Y; Li Z; Wang X; Ma J
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of global differential gene and protein expression in primary Pterygium: S100A8 and S100A9 as possible drivers of a signaling network.
Hou A; Lan W; Law KP; Khoo SC; Tin MQ; Lim YP; Tong L
PLoS One; 2014; 9(5):e97402. PubMed ID: 24825356
[TBL] [Abstract][Full Text] [Related]
59. DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes.
Sakaguchi M; Murata H; Aoyama Y; Hibino T; Putranto EW; Ruma IM; Inoue Y; Sakaguchi Y; Yamamoto K; Kinoshita R; Futami J; Kataoka K; Iwatsuki K; Huh NH
J Biol Chem; 2014 Aug; 289(34):23389-402. PubMed ID: 25002577
[TBL] [Abstract][Full Text] [Related]
60. Low-level laser therapy induces human umbilical vascular endothelial cell proliferation, migration and tube formation through activating the PI3K/Akt signaling pathway.
Li Y; Xu Q; Shi M; Gan P; Huang Q; Wang A; Tan G; Fang Y; Liao H
Microvasc Res; 2020 May; 129():103959. PubMed ID: 31734375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
